Search for: "August et al v. General Motor Company et al"
Results 21 - 40
of 40
Sort by Relevance
|
Sort by Date
30 Dec 2011, 5:38 pm
Supreme Court found in Staub v. [read post]
15 Oct 2011, 8:02 am
David Almeling supports the general idea. [read post]
26 Sep 2011, 4:42 am
(Class 46) United States US General Can the ITC keep pace? [read post]
24 Sep 2011, 3:58 am
Attorney General, et al. [read post]
14 Aug 2011, 11:31 pm
AnchorPoint, Inc., et. al. [read post]
9 Aug 2011, 9:57 pm
Christopher O'Shea, et al. v. [read post]
19 Oct 2010, 9:41 am
Connecticut, et al., 582 F.3d 309 (2nd Cir. 2009). [read post]
24 Sep 2010, 1:22 pm
Ltd. et al. [read post]
7 Jun 2010, 10:04 am
§9601 et seq. [read post]
7 Jun 2010, 9:54 am
§9601 et seq. [read post]
1 Jun 2010, 11:05 pm
General Foam Plastics Corp (Chicago IP Litigation Blog) District Court Kansas: Third Party infringers have no standing to challenge assignment: KMMentor, LLC v. [read post]
15 Mar 2010, 2:09 pm
Molina v. [read post]
6 Dec 2009, 9:11 pm
Click Here National Union Fire Insurance Company et al. v. [read post]
8 Jun 2009, 2:00 am
(Class 46) India Chennai IP Appellate Board: Well-known trademarks - consumer recollection is key: Societe des Produits Nestle SA v Jai ram (International Law Office) Bombay High Court rules on the infringement of copyright in drawings: Indiana Gratings Private Limited & Anr v Anand Udyog Fabricators Private Limited & Ors (Spicy IP) Is ‘science’ essential for creating patent lawyers: some ‘general’ thoughts… [read post]
8 Jun 2009, 2:00 am
(Class 46) India Chennai IP Appellate Board: Well-known trademarks - consumer recollection is key: Societe des Produits Nestle SA v Jai ram (International Law Office) Bombay High Court rules on the infringement of copyright in drawings: Indiana Gratings Private Limited & Anr v Anand Udyog Fabricators Private Limited & Ors (Spicy IP) Is ‘science’ essential for creating patent lawyers: some ‘general’ thoughts… [read post]
2 Aug 2008, 12:54 am
– Technological Innovation and Intellectual Property), IP and start-ups: (Technological Innovation and Intellectual Property), Innovators: Make sure your company owns the fruits of your open innovation projects: (IP Asset Maximizer Blog), It’s all about the numbers: SuperCrunchers of patent data will gain competitive advantage: (IP Asset Maximizer Blog) Events 4-9 August: Dept Science & Technology indigenous knowledge systems expo and workshop… [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog) Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
